» Articles » PMID: 36323752

Neuroprotective Metabolites Via Fungal Biotransformation of a Novel Sapogenin, Cyclocephagenol

Overview
Journal Sci Rep
Specialty Science
Date 2022 Nov 3
PMID 36323752
Authors
Affiliations
Soon will be listed here.
Abstract

Cyclocephagenol (1), a novel cycloartane-type sapogenin with tetrahydropyran unit, is only encountered in Astragalus species. This rare sapogenin has never been a topic of biological activity or modification studies. The objectives of this study were; (i) to perform microbial transformation studies on cyclocephagenol (1) using Astragalus endophyte, Alternaria eureka 1E1BL1, followed by isolation and structural characterization of the metabolites; (ii) to investigate neuroprotective activities of the metabolites; (iii) to understand structure-activity relationships towards neuroprotection. The microbial transformation of cyclocephagenol (1) using Alternaria eureka resulted in the production of twenty-one (2-22) previously undescribed metabolites. Oxidation, monooxygenation, dehydration, methyl migration, epoxidation, and ring expansion reactions were observed on the triterpenoid skeleton. Structures of the compounds were established by 1D-, 2D-NMR, and HR-MS analyses. The neuroprotective activities of metabolites and parent compound (1) were evaluated against HO-induced cell injury. The structure-activity relationship (SAR) was established, and the results revealed that 1 and several other metabolites had potent neuroprotective activity. Further studies revealed that selected compounds reduced the amount of ROS and preserved the integrity of the mitochondrial membrane. This is the first report of microbial transformation of cyclocephagenol (1).

Citing Articles

A Comprehensive Review of the Diversity of Fungal Secondary Metabolites and Their Emerging Applications in Healthcare and Environment.

Wadhwa K, Kapoor N, Kaur H, Abu-Seer E, Tariq M, Siddiqui S Mycobiology. 2025; 52(6):335-387.

PMID: 39845176 PMC: 11749308. DOI: 10.1080/12298093.2024.2416736.


Biotransformation of selected secondary metabolites by Alternaria species and the pharmaceutical, food and agricultural application of biotransformation products.

Tembeni B, Idowu O, Benrkia R, Boutahiri S, Olatunji O Nat Prod Bioprospect. 2024; 14(1):46.

PMID: 39158793 PMC: 11333692. DOI: 10.1007/s13659-024-00469-5.


Fascinating Furanosteroids and Their Pharmacological Profile.

Dembitsky V Molecules. 2023; 28(15).

PMID: 37570639 PMC: 10419491. DOI: 10.3390/molecules28155669.


Potent telomerase activators from a novel sapogenin via biotransformation utilizing Camarosporium laburnicola, an endophytic fungus.

Kucuksolak M, Yilmaz S, Ballar-Kirmizibayrak P, Bedir E Microb Cell Fact. 2023; 22(1):66.

PMID: 37024895 PMC: 10080871. DOI: 10.1186/s12934-023-02069-3.

References
1.
Bhatti H, Khera R . Biological transformations of steroidal compounds: a review. Steroids. 2012; 77(12):1267-90. DOI: 10.1016/j.steroids.2012.07.018. View

2.
Pimentel M, Molina G, Dionisio A, Marostica Junior M, Pastore G . The use of endophytes to obtain bioactive compounds and their application in biotransformation process. Biotechnol Res Int. 2011; 2011:576286. PMC: 3042614. DOI: 10.4061/2011/576286. View

3.
Ozcinar O, Tag O, Yusufoglu H, Kivcak B, Bedir E . Biotransformation of Neoruscogenin by the Endophytic Fungus Alternaria eureka. J Nat Prod. 2018; 81(6):1357-1367. DOI: 10.1021/acs.jnatprod.7b00898. View

4.
Illanes A, Cauerhff A, Wilson L, Castro G . Recent trends in biocatalysis engineering. Bioresour Technol. 2012; 115:48-57. DOI: 10.1016/j.biortech.2011.12.050. View

5.
Simic S, Zukic E, Schmermund L, Faber K, Winkler C, Kroutil W . Shortening Synthetic Routes to Small Molecule Active Pharmaceutical Ingredients Employing Biocatalytic Methods. Chem Rev. 2021; 122(1):1052-1126. DOI: 10.1021/acs.chemrev.1c00574. View